Celgene profit beats as psoriasis drug sales surge

Celgene Corp, which is being bought by Bristol-Myers Squibb Co, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla.


from Reuters: Health News https://reut.rs/2MGE8Yw
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus "With my case, I want to underscore the importance of Nevadans to stay at hom...